Medical Oncologist Joins Practice at Palm Beach County
November . 3, 2020 – Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified hematologist and medical oncologist Mahdi Taha, DO, FACOI, FACP. He is providing care to patients at the FCS Delray location at 5130 West Linton Blvd., Suite B-4, Delray Beach, FL.
Dr. Taha earned his medical degree from New York College of Osteopathic Medicine in Old Westbury, NY. After completing his residency in internal medicine at the Oklahoma State University Medical Center in Tulsa, OK, he was awarded a fellowship at Cancer Treatment Centers of America through Oklahoma State University, where he was named medical oncology chief fellow.
Prior to joining FCS, Dr. Taha volunteered for the American Red Cross Haiti Disaster Relief team, where he cared for patients in Port-Au-Prince. After returning from Haiti, he worked as an associate medical director at Octapharma Plasma Center, Inc. in Atlanta, GA, as an adjunct clinical professor for the Morehouse School of Medicine in Atlanta, GA and as lead medical oncologist at the Cancer Treatment Centers of America and Research Center. Dr. Taha received the Georgia Trend Magazine “40 Under 40 for 2019” award and the Castle Connolly Top Doctor Award in 2018, 2019 and 2020.
Dr. Taha has a strong interest in research with a focus in prostate, lung and pancreatic cancers. He has served on various research committees and participated as principal investigator during several clinical trial studies. Dr. Taha has given presentations at conferences including the ACOI National Convention Case Presentation in San Antonio, Texas, which won the First Place National Award, and serves as a medical consultant for Eisai Pharmaceuticals, Novartis Pharmaceuticals, CBS – “Atlanta Plugged In,” Genentech BioOncology and Merck Pharmaceutical Inc.
FCS CEO Nathan H. Walcker said, “Dr. Taha exhibits a true passion for cancer research. With his track record of educating the community about health and medicine, he will be a strong addition to our new, state-of-the-art Delray practice.”
“Dr. Taha shows admirable interest in clinical research, as demonstrated by his involvement in numerous clinical trials as lead investigator,” said FCS President & Managing Physician Dr. Lucio Gordan. “Our patients will benefit immensely from his expertise in cancer care and research. We are delighted to welcome him to FCS,” Dr. Gordan concluded.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
